KIMS

KIMS shares jump 2% as Q4 net profit rises 47% YoY to Rs 106 crore

Nifty 50 top gainers this week: KIMS, Aavas Financiers, Tata Communications and more

KIMS signs Operations and Management agreement with Splendid Hospitals, Hyderabad

KIMS signs operations and management agreement with Ushahkal Abhinav Institute of Medical Sciences

Under the terms of the agreement, KIMS will receive a 9% revenue fee based on the hospital’s net revenue, calculated in accordance with Indian GAAP (excluding indirect taxes and other income).

KIMS Q3 FY25 results: Net profit jumps 81% YoY to Rs 319.3 crore, revenue increases 21% YoY

Showing strong financial performance despite increased costs. Profit After Tax (PAT) for Nine Months (FY24-25) amounted to ₹25.07 crore.

KIMS shares surge nearly 2% after HSBC raises target price to Rs 670

KIMS increases stake in Sunshine Hospital to 66.35% with Rs 36.88 crore acquisition

KIMS signs MoU with Wipro GE Healthcare worth upto Rs 700 crore

KIMS share price surges 4% in trade after HSBC initiates Buy call, expects 20% upside

HSBC initiates Buy call on KIMS, expects 20.7% upside in the stock price

HSBC has initiated coverage on Krishna Institute of Medical Sciences (KIMS) with a "Buy" rating and a target price of ₹3,300 per share, suggesting a 20.7% upside from the stock’s closing price of ₹2,734 on September 12.

KIMS shares change hands in pre-market block deal worth ₹392.1 crore